CAT and Wyeth-Ayerst in Alzheimer's deal

Cambridge Antibody Technology (LSE:CAT) granted Wyeth-Ayerst, a division of American Home Products (AHP), an exclusive license to develop antibody therapeutics specific for the amyloid beta peptide as...